We tested the effect of p53 status on response to AH54 and AH63 using isogenic HCT116 cells that were either p53 wildtype (+/+), p53 null (−/−), or p53 mutated (S248W/-) carrying a common cancer mutation in the DNA binding domain of the p53 protein. This evidence concerns the gene TP53 and cancer.